Table 1. Oligonucleotide Therapeutics Drug Market Size & CAGR: China VS Global, (US$ Million), 2018-2029

Table 2. Oligonucleotide Therapeutics Drug Market Restraints

Table 3. Oligonucleotide Therapeutics Drug Market Trends

Table 4. Oligonucleotide Therapeutics Drug Industry Policy

Table 5. Global Oligonucleotide Therapeutics Drug Revenue by Company (2018-2023) & (US$ million)

Table 6. Global Oligonucleotide Therapeutics Drug Revenue Market Share by Company (2018-2023)

Table 7. Global Oligonucleotide Therapeutics Drug Manufacturers Market Concentration Ratio (CR3 and HHI)

Table 8. Global Oligonucleotide Therapeutics Drug Mergers & Acquisitions, Expansion Plans

Table 9. Global Oligonucleotide Therapeutics Drug Manufacturers Product Type

Table 10. China Oligonucleotide Therapeutics Drug Revenue by Company (2018-2023) & (US$ million)

Table 11. China Oligonucleotide Therapeutics Drug Revenue Market Share by Company (2018-2023)

Table 12. Global Key Players of Oligonucleotide Therapeutics Drug Upstream (Raw Materials)

Table 13. Global Oligonucleotide Therapeutics Drug Typical Customers

Table 14. Oligonucleotide Therapeutics Drug Typical Distributors

Table 15. By Type, Global Oligonucleotide Therapeutics Drug Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million

Table 16. By Application, Global Oligonucleotide Therapeutics Drug Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million

Table 17. By Region, Global Oligonucleotide Therapeutics Drug Market Size, 2018 VS 2022 VS 2029, US$ Million

Table 18. By Region, Global Oligonucleotide Therapeutics Drug Revenue, 2018-2029, US$ Million

Table 19. By Country, Global Oligonucleotide Therapeutics Drug Revenue & CAGR，2018 VS 2022 VS 2029, US$ Million

Table 20. By Country, Global Oligonucleotide Therapeutics Drug Revenue, 2018-2029, US$ Million

Table 21. By Country, Global Oligonucleotide Therapeutics Drug Revenue Market Share, 2018-2029

Table 22. Biogen Company Information, Head Office, Market Area and Industry Position

Table 23. Biogen Company Profile and Main Business

Table 24. Biogen Oligonucleotide Therapeutics Drug Models, Specifications and Application

Table 25. Biogen Oligonucleotide Therapeutics Drug Revenue and Gross Margin, 2018-2023

Table 26. Biogen Recent Developments

Table 27. Sarepta Therapeutics Company Information, Head Office, Market Area and Industry Position

Table 28. Sarepta Therapeutics Company Profile and Main Business

Table 29. Sarepta Therapeutics Oligonucleotide Therapeutics Drug Models, Specifications and Application

Table 30. Sarepta Therapeutics Oligonucleotide Therapeutics Drug Revenue and Gross Margin, 2018-2023

Table 31. Sarepta Therapeutics Recent Developments

Table 32. Jazz Pharmaceuticals Company Information, Head Office, Market Area and Industry Position

Table 33. Jazz Pharmaceuticals Company Profile and Main Business

Table 34. Jazz Pharmaceuticals Oligonucleotide Therapeutics Drug Models, Specifications and Application

Table 35. Jazz Pharmaceuticals Oligonucleotide Therapeutics Drug Revenue and Gross Margin, 2018-2023

Table 36. Jazz Pharmaceuticals Recent Developments

Table 37. Bausch & Lomb Company Information, Head Office, Market Area and Industry Position

Table 38. Bausch & Lomb Company Profile and Main Business

Table 39. Bausch & Lomb Oligonucleotide Therapeutics Drug Models, Specifications and Application

Table 40. Bausch & Lomb Oligonucleotide Therapeutics Drug Revenue and Gross Margin, 2018-2023

Table 41. Bausch & Lomb Recent Developments

Table 42. Alnylam Pharmaceuticals Company Information, Head Office, Market Area and Industry Position

Table 43. Alnylam Pharmaceuticals Company Profile and Main Business

Table 44. Alnylam Pharmaceuticals Oligonucleotide Therapeutics Drug Models, Specifications and Application

Table 45. Alnylam Pharmaceuticals Oligonucleotide Therapeutics Drug Revenue and Gross Margin, 2018-2023

Table 46. Alnylam Pharmaceuticals Recent Developments

Table 47. Dynavax Technologies Company Information, Head Office, Market Area and Industry Position

Table 48. Dynavax Technologies Company Profile and Main Business

Table 49. Dynavax Technologies Oligonucleotide Therapeutics Drug Models, Specifications and Application

Table 50. Dynavax Technologies Oligonucleotide Therapeutics Drug Revenue and Gross Margin, 2018-2023

Table 51. Dynavax Technologies Recent Developments

Table 52. Kastle therapeutics Company Information, Head Office, Market Area and Industry Position

Table 53. Kastle therapeutics Company Profile and Main Business

Table 54. Kastle therapeutics Oligonucleotide Therapeutics Drug Models, Specifications and Application

Table 55. Kastle therapeutics Oligonucleotide Therapeutics Drug Revenue and Gross Margin, 2018-2023

Table 56. Kastle therapeutics Recent Developments

Table 57. Akcea Therapeutics Company Information, Head Office, Market Area and Industry Position

Table 58. Akcea Therapeutics Company Profile and Main Business

Table 59. Akcea Therapeutics Oligonucleotide Therapeutics Drug Models, Specifications and Application

Table 60. Akcea Therapeutics Oligonucleotide Therapeutics Drug Revenue and Gross Margin, 2018-2023

Table 61. Akcea Therapeutics Recent Developments

List of Figure

Figure 1. Oligonucleotide Therapeutics Drug Picture

Figure 2. Global Oligonucleotide Therapeutics Drug Industry Market Size and Forecast (US$ million) & (2018-2029)

Figure 3. China Oligonucleotide Therapeutics Drug Revenue and Forecast (US$ million) & (2018-2029)

Figure 4. 2018-2029 China Oligonucleotide Therapeutics Drug Market Share of Global

Figure 5. Global Oligonucleotide Therapeutics Drug Key Participants, Market Share, 2021 VS 2022 VS 2023

Figure 6. Global Oligonucleotide Therapeutics Drug Market Share by Company, (Tier 1, Tier 2 and Tier 3), 2018-2023

Figure 7. China Oligonucleotide Therapeutics Drug Key Participants, Market Share, 2021 VS 2022 VS 2023

Figure 8. China Oligonucleotide Therapeutics Drug Revenue, Domestic VS Import Products, Proportion of China Local Players and Foreign Players, 2018-2023

Figure 9. Oligonucleotide Therapeutics Drug Industry Chain

Figure 10. Antisense Oligonucleotide

Figure 11. Aptamer

Figure 12. Other

Figure 13. By Type, Global Oligonucleotide Therapeutics Drug Revenue, 2018-2029, US$ Million

Figure 14. By Type, Global Oligonucleotide Therapeutics Drug Revenue Market Share, 2018-2029

Figure 15. Neuromuscular Diseases

Figure 16. ATTR

Figure 17. Hepatic VOD

Figure 18. Other

Figure 19. By Application, Global Oligonucleotide Therapeutics Drug Revenue, 2018-2029, US$ Million

Figure 20. By Application, Global Oligonucleotide Therapeutics Drug Revenue Market Share, 2018-2029

Figure 21. By Region, Global Oligonucleotide Therapeutics Drug Revenue Market Share, 2018-2029

Figure 22. North America Oligonucleotide Therapeutics Drug Revenue & Forecasts, 2018-2029, US$ Million

Figure 23. By Country, North America Oligonucleotide Therapeutics Drug Revenue Market Share, 2018-2023

Figure 24. Europe Oligonucleotide Therapeutics Drug Revenue & Forecasts, 2018-2029, US$ Million

Figure 25. By Country, Europe Oligonucleotide Therapeutics Drug Revenue Market Share, 2018-2023

Figure 26. Asia Pacific Oligonucleotide Therapeutics Drug Revenue & Forecasts, 2018-2029, US$ Million

Figure 27. By Country/Region, Asia Pacific Oligonucleotide Therapeutics Drug Revenue Market Share, 2018-2023

Figure 28. South America Oligonucleotide Therapeutics Drug Revenue & Forecasts, 2018-2029, US$ Million

Figure 29. By Country, South America Oligonucleotide Therapeutics Drug Revenue Market Share, 2018-2023

Figure 30. Middle East & Africa Oligonucleotide Therapeutics Drug Revenue & Forecasts, 2018-2029, US$ Million

Figure 31. U.S. Oligonucleotide Therapeutics Drug Revenue, 2018-2029, (US$ Million)

Figure 32. By Company, U.S. Oligonucleotide Therapeutics Drug Market Share, 2018-2023

Figure 33. By Type, U.S. Oligonucleotide Therapeutics Drug Revenue Market Share, 2022 VS 2029

Figure 34. By Application, U.S. Oligonucleotide Therapeutics Drug Revenue Market Share, 2022 VS 2029

Figure 35. Europe Oligonucleotide Therapeutics Drug Revenue, 2018-2029, (US$ Million)

Figure 36. By Company, Europe Oligonucleotide Therapeutics Drug Market Share, 2018-2023

Figure 37. By Type, Europe Oligonucleotide Therapeutics Drug Revenue Market Share, 2022 VS 2029

Figure 38. By Application, Europe Oligonucleotide Therapeutics Drug Revenue Market Share, 2022 VS 2029

Figure 39. China Oligonucleotide Therapeutics Drug Revenue, 2018-2029, (US$ Million)

Figure 40. By Company, China Oligonucleotide Therapeutics Drug Market Share, 2018-2023

Figure 41. By Type, China Oligonucleotide Therapeutics Drug Revenue Market Share, 2022 VS 2029

Figure 42. By Application, China Oligonucleotide Therapeutics Drug Revenue Market Share, 2022 VS 2029

Figure 43. Japan Oligonucleotide Therapeutics Drug Revenue, 2018-2029, (US$ Million)

Figure 44. By Company, Japan Oligonucleotide Therapeutics Drug Market Share, 2018-2023

Figure 45. By Type, Japan Oligonucleotide Therapeutics Drug Revenue Market Share, 2022 VS 2029

Figure 46. By Application, Japan Oligonucleotide Therapeutics Drug Revenue Market Share, 2022 VS 2029

Figure 47. South Korea Oligonucleotide Therapeutics Drug Revenue, 2018-2029, (US$ Million)

Figure 48. By Company, South Korea Oligonucleotide Therapeutics Drug Market Share, 2018-2023

Figure 49. By Type, South Korea Oligonucleotide Therapeutics Drug Revenue Market Share, 2022 VS 2029

Figure 50. By Application, South Korea Oligonucleotide Therapeutics Drug Revenue Market Share, 2022 VS 2029

Figure 51. Southeast Asia Oligonucleotide Therapeutics Drug Revenue, 2018-2029, (US$ Million)

Figure 52. By Company, Southeast Asia Oligonucleotide Therapeutics Drug Market Share, 2018-2023

Figure 53. By Type, Southeast Asia Oligonucleotide Therapeutics Drug Revenue Market Share, 2022 VS 2029

Figure 54. By Application, Southeast Asia Oligonucleotide Therapeutics Drug Revenue Market Share, 2022 VS 2029

Figure 55. India Oligonucleotide Therapeutics Drug Revenue, 2018-2029, (US$ Million)

Figure 56. By Company, India Oligonucleotide Therapeutics Drug Market Share, 2018-2023

Figure 57. By Type, India Oligonucleotide Therapeutics Drug Revenue Market Share, 2022 VS 2029

Figure 58. By Application, India Oligonucleotide Therapeutics Drug Revenue Market Share, 2022 VS 2029

Figure 59. Middle East & Asia Oligonucleotide Therapeutics Drug Revenue, 2018-2029, (US$ Million)

Figure 60. By Company, Middle East & Asia Oligonucleotide Therapeutics Drug Market Share, 2018-2023

Figure 61. By Type, Middle East & Asia Oligonucleotide Therapeutics Drug Revenue Market Share, 2022 VS 2029

Figure 62. By Application, Middle East & Asia Oligonucleotide Therapeutics Drug Revenue Market Share, 2022 VS 2029

Figure 63. Research Methodology

Figure 64. Breakdown of Primary Interviews

Figure 65. Bottom-up Approaches

Figure 66. Top-down Approaches